The Effect of Advance Care Planning on Heart Failure: a Systematic Review and Meta-analysis

Markus Schichtel1, Bee Wee2, Rafael Perera3

  • 1Department of Public Health and Primary Care, Primary Care Unit, University of Cambridge, Cambridge, UK. ms2591@medschl.cam.ac.uk.

Insights

Advance care planning (ACP) significantly improves quality of life, patient satisfaction, and end-of-life communication for heart failure patients. Optimal effectiveness is achieved through timely introduction, family involvement, and personalized follow-up.

Area of Science:

  • Cardiology
  • Palliative Care
  • Health Services Research

Background:

  • Advance care planning (ACP) is recommended for improving end-of-life care in heart failure patients.
  • A systematic evaluation of ACP's impact on clinical outcomes was previously lacking.
  • This study aimed to assess the effect of ACP in heart failure via a meta-analysis of randomized controlled trials (RCTs).

Purpose of the Study:

  • To systematically evaluate the impact of advance care planning (ACP) on clinical outcomes in heart failure patients.
  • To synthesize evidence from randomized controlled trials (RCTs) on the effectiveness of ACP in heart failure management.
  • To identify factors influencing the effectiveness of ACP in improving patient outcomes.

Main Methods:

  • A comprehensive literature search was conducted across multiple databases (CINAHL, Cochrane, Embase, MEDLINE, etc.) up to July 2018.
  • Fourteen RCTs involving 2924 adult heart failure patients were included.
  • Data were extracted, risk of bias and evidence quality were assessed using Cochrane and GRADE tools, and pooled effects were calculated using random-effects models.

Main Results:

  • ACP demonstrated a moderate positive effect on quality of life (SMD, 0.38) and patient satisfaction with end-of-life care (SMD, 0.39).
  • A significant improvement was observed in the quality of end-of-life communication (SMD, 0.29).
  • ACP was most effective when initiated at key disease milestones, included family, involved follow-up, and considered ethnic preferences.

Conclusions:

  • Advance care planning (ACP) positively impacts quality of life, patient satisfaction, and communication quality in heart failure patients.
  • The effectiveness of ACP is enhanced by strategic timing, family engagement, consistent follow-up, and cultural sensitivity.
  • ACP is a valuable intervention for improving end-of-life care experiences in individuals with heart failure.
Abstract

Related Concept Videos

Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
379
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
184
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
857
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
264
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.6K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
218